Nancy Patten
Impact in
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
-
- Cancer Genomics and Diagnostics
Papers in
- Genetics 10
- Chronic Lymphocytic Leukemia Research 10
-
- Lymphoma Diagnosis and Treatment 2
- Co-authors
- Lin Wu (5 shared papers)Carl T. Yamashiro (2 shared papers)Lin Wu (2 shared papers)Susanne Schnittger (2 shared papers)Wolfgang Kern (2 shared papers)Torsten Haferlach (2 shared papers)Hannes Herholz (2 shared papers)Claudia Haferlach (2 shared papers)
- Journals
- Blood (7 papers)Leukemia (2 papers)International Journal of Oncology (1 paper)Journal of Clinical Oncology (1 paper)Tumor Biology (1 paper)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Nancy Patten
20 papers receiving 1.3k citations
Nancy Patten's Hit Papers
Peers
Comparison fields: 5 of 58
- Genetics 752
- Cancer Research 86
- Oncology 133
- Pathology and Forensic Medicine 89
- Pharmacology 28
Countries citing papers authored by Nancy Patten
This map shows the geographic impact of Nancy Patten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Patten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Patten more than expected).
Fields of papers citing papers by Nancy Patten
This network shows the impact of papers produced by Nancy Patten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Patten. The network helps show where Nancy Patten may publish in the future.
Co-authors
The 25 scholars most cited alongside Nancy Patten, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial Hit paper breakdown → | 2014 | 435 |
| 2 | 2008 | 182 | |
| 3 | 2010 | 133 | |
| 4 | 2006 | 123 | |
| 5 | 2007 | 111 | |
| 6 | 2002 | 70 | |
| 7 | 2013 | 62 | |
| 8 | 2010 | 50 | |
| 9 | 2012 | 33 | |
| 10 | 2013 | 33 | |
| 11 | 2002 | 31 | |
| 12 | 2000 | 30 | |
| 13 | 2011 | 24 | |
| 14 | 2002 | 19 | |
| 15 | 2006 | 16 | |
| 16 | 2014 | 11 | |
| 17 | 2008 | 3 | |
| 18 | Complete p53 multi-exon sequencing by gene chip complements use of p53 immunohistochemistry for prediction of clinical outcome in invasive bladder cancer | 2004 | 2 |
| 19 | 2007 | 2 | |
| 20 | 2009 | 1 |
About Nancy Patten
Nancy Patten is a scholar working on Genetics, Pathology and Forensic Medicine, Pharmacology, Reproductive Medicine and Cancer Research, having authored 20 papers that have together received 1.4k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (10 papers), Lymphoma Diagnosis and Treatment (2 papers), Bladder and Urothelial Cancer Treatments (2 papers), Pharmacogenetics and Drug Metabolism (1 paper), Axon Guidance and Neuronal Signaling (1 paper), Ovarian cancer diagnosis and treatment (1 paper), Global Cancer Incidence and Screening (1 paper) and Cancer-related Molecular Pathways (1 paper). The work is most often cited by research in Genetics (752 citations), Cancer Research (86 citations), Oncology (133 citations), Pathology and Forensic Medicine (89 citations) and Pharmacology (28 citations). Nancy Patten has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Lin Wu, Carl T. Yamashiro, Lin Wu, Susanne Schnittger, Wolfgang Kern, Torsten Haferlach, Hannes Herholz, Claudia Haferlach, Frank Dicker and Sylvain L’Espérance. Their work appears in journals such as Blood, Leukemia, International Journal of Oncology, Journal of Clinical Oncology and Tumor Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.